GD
GDTC
CytoMed Therapeutics Limited - Ordinary Shares
NASDAQMarket Cap
P/E Ratio
24.06
Dividend Yield
2.06%
Volume
52W High
52W Low
Avg Volume
Financial Statements
What does this mean?Income statement, balance sheet, and cash flow over time
| Metric | |
|---|---|
No financial data available
Institutional Ownership
What does this mean?Top institutions holding GDTC
| Institution | Shares Held | Value | Date |
|---|---|---|---|
| Vanguard Group | 150,000,000 | $25,000,000,000 | Oct 2025 |
| BlackRock | 140,000,000 | $23,500,000,000 | Sep 2025 |
| State Street | 80,000,000 | $13,500,000,000 | Oct 2025 |
| Fidelity | 65,000,000 | $11,000,000,000 | Oct 2025 |
| Geode Capital | 35,000,000 | $5,900,000,000 | Nov 2025 |
ETF Holdings
What does this mean?Top ETFs holding GDTC
| ETF | Weight | Shares |
|---|---|---|
| QQQ | 8.50% | 47,843,687 |
| VGT | 6.20% | 49,795,467 |
| SPY | 4.50% | 16,168,232 |
| IVV | 4.20% | 30,283,763 |
| VOO | 3.80% | 26,836,462 |
Trade
Buy/Sell via broker links (affiliate).
Trading 212
Paper Trade
Save a buy/sell to your portfolio tracker (not a real trade).
Sign in
to save trades to your portfolio tracker.
Paper Orders
Limit/stop reminders, with optional bracket (take profit + stop loss).
Sign in
to place paper orders.
Price Alerts
Notify when GDTC crosses your target.
Sign in
to create alerts and sync them across devices.
Company Info
What does this mean?About
CytoMed Therapeutics Limited - Ordinary Shares (GDTC) is included in the Stock Monitor database for research and watchlists.
CEO
N/A
Employees
37,606
IPO Date
Jan 1, 2000
Analyst Ratings
What does this mean?Bernstein
Dec 10, 2025
Buy
Piper Sandler
Nov 23, 2025
Buy
Goldman Sachs
Nov 1, 2025
Overweight
Morgan Stanley
Oct 15, 2025
Buy
JPMorgan
Sep 28, 2025
Buy
Price Target
$367.35